Bulk Pharmaceutical API Sources for NORMOZIDE

Bulk Pharmaceutical API Sources for NORMOZIDE

Vendor	Vendor Homepage	Vendor Sku	API Url
Hangzhou Trylead Chemical Technology		TL8002725
NovoSeek		3869
MolPort		MolPort-003-898-140
Hangzhou APIChem Technology		AC-18747
ABI Chem		AC1L1GW8
ChemMol		30106741
ChemMol		44004898

Bulk Active Pharmaceutical Ingredient (API) Sources for Normozide

Last updated: August 2, 2025

Introduction

Normozide, also known by its chemical name chlorpropamide, is an oral antidiabetic medication approved for managing type 2 diabetes mellitus. It belongs to the sulfonylurea class, stimulating pancreatic insulin secretion. As a critical component in pharmaceutical manufacturing, sourcing high-quality bulk API is essential for efficacy, safety, and regulatory compliance. This article explores the global landscape of bulk API suppliers for Normozide, analyzing key manufacturers, geographical distribution, quality standards, and sourcing considerations relevant for pharmaceutical companies.

Overview of Normozide (Chlorpropamide) and Its API

Chlorpropamide's chemical formula is C8H9ClN2O3S, with a molecular weight of approximately 284 g/mol. The API's stability, bioavailability, and potency hinge on strict manufacturing processes adhering to Good Manufacturing Practices (GMP). The global demand for Normozide APIs is driven by the prevalence of type 2 diabetes, especially in emerging markets, necessitating reliable suppliers to meet quality and volume requirements.

Global API Manufacturers of Normozide

1. Major International API Producers

a. Jiangsu Hengrui Medicine Co., Ltd. (China)

Jiangsu Hengrui is a leading Chinese pharmaceutical company with a comprehensive portfolio of APIs, including chlorpropamide. The company adheres to rigorous GMP standards aligned with international regulatory agencies, enabling exports to global markets. They possess robust R&D capabilities and large-scale manufacturing facilities, making them a preferred partner for bulk API procurement.

b. Zhejiang Huahai Pharmaceutical Co., Ltd. (China)

Huahai specializes in generic APIs and has a longstanding reputation for quality control and cost-effective manufacturing. Their chlorpropamide API production complies with US FDA and European EMA standards, supporting exportation to North America and Europe. The company's extensive global distribution network facilitates prompt delivery and responsive customer service.

c. Sandoz (Novartis division, Switzerland)

As a global leader in generics and biosimilars, Sandoz's API division maintains state-of-the-art manufacturing facilities that meet stringent international standards. While primarily focused on high-demand APIs, Sandoz offers custom manufacturing and supplies APIs to large pharmaceutical firms seeking high-quality standards.

d. Teva Pharmaceutical Industries Ltd. (Israel)

Teva operates several API manufacturing sites adhering to GMP, producing chlorpropamide among other antidiabetics. The company's scale and global distribution channels ensure reliable bulk API sources, especially for markets with regulatory approvals.

e. Lupin Limited (India)

Lupin's integrated API and formulations manufacturing capabilities include chlorpropamide. Their facilities are approved by major global health authorities, and the company emphasizes cost efficiency and consistent quality.

2. Regional API Manufacturers

a. India

India remains a dominant API manufacturing hub, with numerous small to mid-sized producers supplying chlorpropamide. Companies such as Aurobindo Pharma, Cipla, and Natco Pharma produce APIs compliant with international standards, often at lower costs.

b. China

China’s API industry continues to dominate global supplies due to economies of scale and raw material availability. Besides Huawei and Hengkang Medical, smaller regional factories also contribute to the supply chain, often catering to generic markets.

c. Europe and North America

While fewer in number, European and North American companies focus on high compliance and specialty APIs. Sandoz and Teva are the notable suppliers providing APIs with comprehensive regulatory documentation suitable for GMP-certified pharmaceutical manufacturing.

Quality Standards and Regulatory Compliance

Ensuring API quality involves adherence to GMP guidelines, ICH Q7 standards, and regulatory authorities such as the U.S. Food & Drug Administration (FDA), European Medicines Agency (EMA), and the Pharmaceuticals and Medical Devices Agency (PMDA) in Japan. Suppliers often provide Certificates of Analysis (CoA), Certificates of Suitability (CEP), or Drug Master Files (DMF) to facilitate regulatory filings.

Regulatory intelligence indicates increasing scrutiny of API sourcing, emphasizing transparency, traceability, and validation processes. Suppliers compliant with these standards minimize regulatory risks and ensure uninterrupted manufacturing processes.

Sourcing Considerations for Normozide APIs

• Quality and Compliance: Choose suppliers with validated manufacturing processes and regulatory approvals to meet safety and efficacy standards.
• Cost and Pricing: Evaluate total cost, including freight, taxes, and tariffs, especially from emerging markets.
• Supply Chain Reliability: Assess vendor capacity, production lead times, and inventory management capabilities.
• Regulatory Support: Consider vendors’ ability to provide necessary documentation, audits, and compliance certifications.
• Intellectual Property: Confirm ownership rights and licensing agreements, particularly for generic APIs to avoid infringement.

Emerging Trends and Future Outlook

The global appetite for high-quality generic APIs like chlorpropamide is expected to grow, driven by escalating diabetes rates worldwide. The trend toward consolidation among API producers enhances compliance, scale, and innovation. Additionally, manufacturers investing in green chemistry and sustainable practices align with industry shifts toward environmental responsibility.

Suppliers are increasingly offering integrated solutions—covering raw material sourcing, manufacturing, and regulatory support—to meet complex demand chains. Companies integrating digital tracking and blockchain technology foster greater transparency and traceability in API sourcing.

Conclusion

Reliable sourcing of Normozide (chlorpropamide) API hinges on selecting manufacturers that balance quality, cost, and regulatory compliance. Major players like Jiangsu Hengrui, Zhejiang Huahai, and Teva provide reputable options globally, with additional regional manufacturers offering cost-effective alternatives suited to specific markets. Pharmaceutical companies should prioritize suppliers compliant with international standards, maintain comprehensive regulatory documentation, and establish strategic partnerships for long-term supply stability.

---

Key Takeaways

• The global API market for Normozide is primarily dominated by Chinese manufacturers, with significant contributions from India and established European and Israeli firms.
• Regulatory compliance, GMP adherence, and transparent documentation are critical criteria for API sourcing.
• Regional supply chains offer cost advantages but require rigorous validation to meet international quality standards.
• Future growth in API demand emphasizes the need for suppliers investing in sustainable practices and digital traceability.
• Strategic sourcing involves balancing quality assurance, cost efficiency, and supply chain reliability to optimize pharmaceutical manufacturing.

---

FAQs

1. What are the primary considerations when sourcing Normozide API?
Quality compliance, regulatory approvals, manufacturing capacity, cost, and supply chain reliability are vital considerations to ensure product safety and consistent supply.

2. Which regions dominate the global manufacture of chlorpropamide API?
China and India are the leading regions, offering the majority of bulk API supply due to manufacturing scale and cost advantages.

3. How do suppliers ensure API quality and regulatory compliance?
By adhering to GMP standards, obtaining certifications like FDA approval or CEP, and providing comprehensive documentation like CoAs and validation reports.

4. What are the emerging trends in API sourcing for antidiabetics like Normozide?
Increased emphasis on sustainability, digital traceability, supplier consolidation, and integrated supply chain solutions.

5. Can smaller API manufacturers meet international regulatory standards?
Yes, many smaller manufacturers in India and China achieve compliance through GMP certification, but due diligence and validation are necessary for quality assurance.

---

References

1. [1] U.S. FDA. (2022). Guidance for Industry: GMP for Active Pharmaceutical Ingredients.
2. [2] International Council for Harmonisation (ICH). (2016). ICH Q7: Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients.
3. [3] PharmaSource. (2022). Global API Market Data & Trends.
4. [4] European Medicines Agency. (2022). API Quality Standards and Regulatory Requirements.
5. [5] Chinese State Food and Drug Administration (SFDA). (2021). API Manufacturing Licensing and Compliance.